Clinical evaluation of MyoCare in Europe (CEME) for myopia management: One‐year results
Ophthalmic and Physiological Optics · 2025-06 · 45 (4) · 1025-1035
DOI: 10.1111/opo.13517 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ophthalmic and Physiological Optics, online erschienen am 29.04.2025. Verfasst von Cristina Alvarez-Peregrina und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Optometry and Vision, Faculty of Optics and Optometry, Universidad Complutense de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Eyeglasses, Myopia, Refraction, Ocular, Visual Acuity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zeiss Vision Care.
Abstract (Originalsprache)
Aims
To evaluate the efficacy of CARE spectacle lenses in slowing myopia progression among European children.
Methods
In a 2‐year randomised, parallel‐group, double‐masked, multicentre clinical trial, 234 European children aged 6–13 years were enrolled. All participants were myopic, with a cycloplegic spherical equivalent refractive error (SE) between −0.75 D and −5.00 D, astigmatism ≤1.50 D, anisometropia ≤1.00 D and myopia progression of at least 0.50 D in the previous year. The treatment group received MyoCare spectacle lenses with cylinder annular refractive elements (CARE), the control group single‐vision lenses (SVL). Axial length (AL) and SE were measured at baseline, 6 and 12 months. Wearability questionnaires were administered at 1 week and 3 months. Central and peripheral visual acuity (VA) was recorded at dispensing and after 3 months. Generalised linear models estimated changes in SE and AL, adjusting for lens type, age and baseline measurements.
Results
After 12 months, children wearing CARE lenses showed less myopia progression, with a difference in SE and AL progression (compared to SVL) of −0.21 D (CI: 0.10 to 0.32 D) and 0.14 mm (CI: −0.17 to −0.10 mm), respectively. Central VA did not decrease with CARE lenses. Peripheral VA decreased by 0.10 and 0.09 logMAR in the nasal and temporal zones, respectively. Analysis of fast progressors indicated that 39.7% of SVL wearing eyes progressed by ≤−0.50 D/year compared to 21.1% with CARE ( p < 0.01). For AL, 56.0% of SVL children had an elongation ≥0.20 mm compared to 21.3% with CARE ( p < 0.01).
Conclusions
In European children, myopia progression was significantly slower with CARE lenses compared with SVL after 1 year of lens wear. Further monitoring will provide a comprehensive evaluation of long‐term efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Optometry and Vision, Faculty of Optics and Optometry, Universidad Complutense de Madrid, Madrid, Spain.
- ISEC LISBOA-Instituto Superior de Educação e Ciências, Lisbon, Portugal.
- Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain.
- School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.
- ZEISS Vision Care, Carl Zeiss Vision International GmbH, Aalen, BW, Germany.
- ZEISS Vision Care, Carl Zeiss Vision (Guangzhou) Ltd., Guangzhou, China.
ORCID-Profile: Cristina Alvarez-Peregrina, Miguel Angel Sanchez-Tena, Cesar Villa-Collar, Clara Martinez-Perez, Nicole Liu, Padmaja Sankaridurg, Arne Ohlendorf
Förderung
- Zeiss Vision Care
Zitieren
APA
Alvarez-Peregrina, C., Sanchez-Tena, M. A., Villa-Collar, C., Martinez-Perez, C., de Corcuera-Terrero, B., Liu, N., Li, W., Sankaridurg, P., Ohlendorf, A., & Clinical Evaluation of MyoCare in Europe – the CEME Study Group (2025). Clinical evaluation of MyoCare in Europe (CEME) for myopia management: One‐year results. Ophthalmic and Physiological Optics, 45(4), 1025-1035. https://doi.org/10.1111/opo.13517
Vancouver
Alvarez-Peregrina C, Sanchez-Tena MA, Villa-Collar C, Martinez-Perez C, de Corcuera-Terrero B, Liu N, et al. Clinical evaluation of MyoCare in Europe (CEME) for myopia management: One‐year results. Ophthalmic and Physiological Optics. 2025;45(4):1025-1035. doi:10.1111/opo.13517
BibTeX
@article{AlvarezPeregrina2025,
author = {Alvarez-Peregrina, Cristina and Sanchez-Tena, Miguel Angel and Villa-Collar, Cesar and Martinez-Perez, Clara and de Corcuera-Terrero, Beatriz and Liu, Nicole and Li, Wayne and Sankaridurg, Padmaja and Ohlendorf, Arne and Clinical Evaluation of MyoCare in Europe – the CEME Study Group, Clinical Evaluation of MyoCare in Europe – the CEME Study Group},
title = {Clinical evaluation of MyoCare in Europe (CEME) for myopia management: One‐year results},
journal = {Ophthalmic and Physiological Optics},
year = {2025},
volume = {45},
number = {4},
pages = {1025--1035},
doi = {10.1111/opo.13517}
}
EUVIMED